Management

Clay B. Siegall, Ph.D.
President, Chief Executive Officer
and Chairman of the Board

Eric L. Dobmeier
Chief Operating Officer

Jonathan Drachman, M.D.
Chief Medical Officer and
Executive VP, Research and Development

Todd E. Simpson
Chief Financial Officer

Chris Boerner, Ph.D.
Executive VP, Commercial

Vaughn B. Himes, Ph.D.
Executive VP, Process Sciences
and Technical Operations

Christopher Pawlowicz
Senior VP, Human Resources

Eric Sievers, M.D.
Senior VP, Clinical Development

Elaine Waller, Pharm.D.
Senior VP, Regulatory Affairs and
Clinical Development Operations

Peter Senter, Ph.D.
VP, Chemistry and Distinguished Fellow

You are now leaving Seattle Genetics' site. Seattle Genetics does not necessarily endorse the organization associated with this link and takes no responsibility for the content contained therein. This resource link is for informational purposes only. Do you want to continue to the external site and leave SeattleGenetics.com?

No, return to SeattleGenetics.com

Yes, leave SeattleGenetics.com